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Pheochromocytoma
Aaron Mitchell Corn RN, BSN
Otterbein University, Westerville, Ohio
Pathophysiology of Pheochromocytomas
Pheochromocytomas are
neuroendocrine tumors that
have their origins in the
adrenal medulla chromaffin
cells (Soltani et al., 2017).
•
The chromaffin cells are part
of the sympathetic nervous
system and are responsible
for secreting catecholamines
into systemic circulation
(Soltani et al., 2017).
•
These catecholamines are
epinephrine (80%) and
norepinephrine (20%). In
high concentrations, these
hormones can cause
unregulated hypertension
(Soltani et al., 2017).
•
Pheochromocytomas can be
classified into 3 different
categories based on what
catecholamine they secrete.
1.
Epinephrine-secreting
tumor
2.
Norepinephrine-secreting
tumor
3.
Dopamine-secreting tumor
(Soltani et al., 2017)
•
These catecholamines have
varying effects on different
receptors throughout the
body. Primarily, the
receptors that are clinically
significant are the beta
adrenergic receptors and
alpha adrenergic receptors
(Soltani et al., 2017).
•
Stimulation of the beta
adrenergic receptors by
these catecholamines causes
increased contractility and
heart rate (Soltani et al.,
2017).
•
Stimulation of alpha
adrenergic receptors induces
vasoconstriction, resulting in
hypertension (Soltani et al.,
2017).
•
The myocardium is sensitive
to these catecholamines and
chronic exposure can result
in myocardial fibrosis
(Soltani et al., 2017).
•
Thus it is important to
recognize these tumors early
and intervene so that longlasting effects are not
permanent (Soltani et al.,
2017).
•

•

•

•

•

•

•

•

Epinephrine-secreting tumors can
stimulate beta 2 adrenergic
receptors which will cause
vasodilatation instead of
vasoconstriction. Vasodilatation
can result in episodes of
hypotension (Soltani et al., 2017).
This is an important fact to
remember because the majority of
pheochromocytomas secrete
norepinephrine, which primarily
stimulates alpha adrenergic
receptors, causing vasoconstriction
and hypertension (Soltani et al.,
2017).
Immature tumors are sometimes
missing dopamine β-hydroxylase,
which is the converting enzyme of
dopamine to norepinephrine
(Soltani et al., 2017).
Thus, dopamine-secreting
pheochromocytomas may be found.
These tumors indicate a higher
likelihood of malignancy (Soltani et
al., 2017).
Pheochromocytomas can release
norepinephrine, dopamine or
epinephrine continuously or
paroxysmally (Soltani et al., 2017).
The sudden release of these
catecholamines from
pheochromocytomas typically
cause hypertension, headache and
diaphoresis (Soltani et al., 2017).
This triad of symptoms is known as
“an attack” (Soltani et al., 2017).

Clinical Presentation
•

•

•

•

•

Roughly 10-40% of
pheochromocytomas are not
found due to
symptomatology. In these
cases, the tumors are found
during unrelated imaging
(Ramachandran & Rewari,
2017).
The classic triad of
symptoms are headache,
heart palpitations and
diaphoresis (Ramachandran
& Rewari, 2017). These
symptoms are found in
roughly 40% of patients.
Pheochromocytomas have
been referred to as “the
Great Mimic” due to their
similarities to many other
illnesses (Soltani et al.,
2017).
Patients present to their
primary care physicians with
complaints of weakness,
panic attacks, nausea and
vomiting, and the classic
triad (Paknikar, 2015).
One of the main factors that
clinicians consider is the
episodic nature of
pheochromocytomas. Most
pheochromocytomas that
cause symptoms will do so
in paroxysmal fashion
(Lenders & Eisenhofer,
2017).

•
•
•
•
•
•

The Importance of Understanding
Pheochromocytomas

•

Introduction

•

Pheochromocytomas are rare neuroendocrine tumors that originate from
chromaffin cells in the adrenal medulla (Tian et al., 2019).
These tumors can have vast and devastating effects on a patient’s cardiovascular
system, potentially leading to hemodynamic instability (Tian et al., 2019).
They exert their effects by releasing catecholamines, such as norepinephrine, into
the bloodstream, which leads to labile fluctuations in a patient’s blood pressure
(Tian et al., 2019).
In 1937, Dr. Charles Mayo was the first to clinically diagnose and surgically remove
a pheochromocytoma tumor (Mubarik & Aeddula, 2020).
Although pheochromocytoma tumors are rare, they pose an incredible risk to a
patient’s outcome if not treated properly (Fermandois et al., 2020).
Nurse anesthetists need to understand the pathophysiology of these tumors so
that they can adequately and safely manage the hemodynamic fluctuations that
can be seen.

Figure 2 illustrates the physiological action that norepinephrine
exerts on alpha adrenergic receptors located in smooth muscle.
Stimulation of the alpha 1 adrenergic receptor by norepinephrine
results in contraction of smooth muscle lining the walls of blood
vessels, leading to an increase in blood pressure (Klabunde, 2013).

•

•

•

Illustration depicting a Pheochromocytoma

•

Pheochromocytomas are diagnosed
based on blood and urine tests
(Paknikar, 2015).
Catecholamines in the body are
broken down into inactive
metabolites by enzymes (Paknikar,
2015).
These metabolites, metanephrine
and normetanephrine, can be
detected at elevated levels in the
blood and urine (Paknikar, 2015).
Before the tests are performed,
patients are advised to avoid certain
drugs such as tricyclic
antidepressants and acetaminophen
due to their ability to skew results
(Paknikar, 2015).
Additionally, imaging such as CT
scans and MRI can be used to detect
the tumor and assess whether it has
spread (Paknikar, 2015).

•

•

Treatment
•

•

•

(Paknikar, 2015)

(Klabunde, 2013)

Risk Factors

Diagnosis

Figure 1 depicts the origin of pheochromocytomas. These tumors arise
from the adrenal glands that sit on top of the kidneys (Soltani et al., 2017).
Because these tumors stem from chromaffin cells within the adrenal
medulla, they can oversecrete endogenous catecholamines into the systemic
circulation (Soltani et al, 2017). Overproduction of catecholamines can lead
to significant episodes of hypertension, tachycardia, and diaphoresis
(Mubarik & Aeddula, 2020).
The main treatment for pheochromocytomas is surgical removal
(Lenders & Eisenhofer, 2017). Thus, it is of utmost importance that the
anesthesia provider understands the pathological process of these tumors.
Without proper knowledge and treatment plan, pheochromocytomas can
cause catastrophic hemodynamic instability in the anesthetized patient
(Lenders & Eisenhofer, 2017).

•

•

•

Pheochromocytomas can be
surgically removed to prevent the
release of catecholamines and
reduce the risk of malignancy and
metastatsis (Tauzin-Fin et al.,
2019).
Patients with symptomatic and
unpredictable
pheochromocytomas must receive
medical management between
10-14 days before surgery (Garica
et al., 2019).
Medical management involves the
administration of
phenoxybenzamine, a
noncompetitive and nonselective
alpha-blocking agent (Garcia et al.,
2019).
Phenoxybenzamine will prevent
the tumor’s secretion of excess
catecholamines from causing
extensive vasoconstriction,
resulting in hypertension (TauzinFin et al., 2019).
Beta adrenergic receptor blockade
is also established to prevent
tachyarrythmias from occurring
during surgery (Garcia et al.,
2019).
During medical management it is
of utmost importance to block the
alpha-adrenergic effects of the
catecholamines before
administering a beta adrenergic
receptor blocker due to the risk of
acute cardiac failure as a s result
of unopposed vasoconstriction
(Garcia et al., 2019).

Current literature states
that the exact cause of
pheochromocytomas is
unknown but several genes
have been associated with
its occurrence (Paknikar,
2015).
Mubarik and Aeddula et al.
(2020) suggests that
roughly 90% of cases are
random with no definitive
link.
Additionally, 10% can be
linked to familial
inheritance or the presence
of syndromes like Von
Hippel–Lindau syndrome,
type 1 neurofibromatosis,
and multiple endocrine
neoplasia syndromes type
IIA and type IIB with an
autosomal dominant mode
of transmission (Mubarik &
Aeddula, 2020).

Anesthesia
Considerations
•

•

•

•

•

•

Surgery to remove a
pheochromocytoma is considered a
high-risk surgery due to the
possibility of hemodynamic
instability (Garcia et al., 2019).
Constant communication between
the surgical and anesthesia team is
important to relay information such
as initial incision, division of blood
supply from tumor and any
manipulation of the tumor (Garcia
et al., 2019).
Blood pressure fluctuations is one
of the most important vital signs to
monitor, thus invasive monitoring
with an arterial line is needed
(Garcia et al., 2019).
Central venous access may be
warranted due to the many types of
medications, fluids and monitoring
that is required (Garcia et al., 2019).
The fluid volume status of the
patient should be monitored
carefully. Underhydration could
result in significant hypotension,
while overhydration could result in
cardiac failure and pulmonary
edema (Garcia et al., 2019).
Important medications to have
ready are vasodilators,
vasoconstrictors, anti-arrythmias
such as lidocaine, and fluids (Garcia
et al., 2019).
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